Design and rationale of the PERSEVERE study: a randomized controlled trial of large-bore mechanical thrombectomy versus the standard of care for high-risk pulmonary embolism

29 August 2025 (07:00 - 18:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Professor Nicolas Meneveau

Regional University Hospital Jean Minjoz, Besancon (France)

4 More presentations in this session

Presentation thumbnail

Patient-specific Display of Treatment Information and Adherence to Clinical Practice Guideline Recommendations (PEER-APP): a dual center, blinded randomized controlled trial

Doctor C. Scherer (Munich, DE)

Abstract Slides Video

Presentation thumbnail

The inclusion of cancer in heart failure risk assessment tool for patients with type-2 diabetes mellitus: a precision medicine approach

Doctor N. Kaur (Glasgow, GB)

Abstract Slides Video

Presentation thumbnail

Non-contact biometric system for detecting hypertension and diabetes using artificial intelligence and spectral imaging

Ms R. Uchida (Tokyo, JP)

Abstract Slides Video

Presentation thumbnail

Simplified regimen for the management of hypertension with telemedicine and blood pressure self-monitoring (SIMPLE): an open-label, multicenter, randomized controlled trial

Professor Y. Zhang (Shanghai, CN)

Abstract Slides Video

Access the full session

Session thumbnail

Precision diagnostics to guide precision therapy

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025

You may be interested in

Congress Presentation

Insights from STORM PE: first RCT in aspiration thrombectomy vs. standard of care

Congress Session

Acute pulmonary embolism: new approaches for an old killer

Congress Session

Shaping the future of pulmonary embolism (PE) treatment using mechanical thrombectomy

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources